Point Out Caveats With Direct-to-Consumer Meds

January 2026

More drug companies and third-party platforms are selling Rx meds directly to patients...such as Eliquis, Wegovy, Xofluza, and Zepbound.

These direct-to-consumer (DTC) Rx programs appeal to patients by offering discounted and transparent pricing, convenience, privacy, etc.

But point out that not all DTC programs translate into big savings...and there can be other caveats. Help weigh pros and cons.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote